Q3 2025 Earnings Call Transcript November 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.40538, expectations were $-1.91. Operator: Good morning, ladies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback